| Title |
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
|
|---|---|
| Published in |
Advances in Therapy, October 2017
|
| DOI | 10.1007/s12325-017-0612-x |
| Pubmed ID | |
| Authors |
Gilles Salles, Martin Barrett, Robin Foà, Joerg Maurer, Susan O’Brien, Nancy Valente, Michael Wenger, David G. Maloney |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 563 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 563 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 86 | 15% |
| Student > Master | 71 | 13% |
| Student > Ph. D. Student | 50 | 9% |
| Researcher | 47 | 8% |
| Other | 35 | 6% |
| Other | 95 | 17% |
| Unknown | 179 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 153 | 27% |
| Biochemistry, Genetics and Molecular Biology | 83 | 15% |
| Immunology and Microbiology | 36 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 31 | 6% |
| Agricultural and Biological Sciences | 26 | 5% |
| Other | 43 | 8% |
| Unknown | 191 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 October 2023.
All research outputs
#4,726,082
of 26,017,215 outputs
Outputs from Advances in Therapy
#453
of 2,677 outputs
Outputs of similar age
#76,026
of 334,969 outputs
Outputs of similar age from Advances in Therapy
#5
of 28 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,677 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,969 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.